Captagon, a synthetic stimulant, has gained notoriety for its role in the Syrian conflict, with implications for the economy and governance in the region. The drug, originally developed for medical use, has found a significant market within Syria and beyond, generating substantial revenues for factions involved in the war, particularly the Assad regime. This article explores the origins, production, and impact of Captagon, as well as the broader implications for drug trafficking and regional stability.